ATXI
Avenue Therapeutics, Inc.Company with tickers: ATXI
CIK
1644963
CUSIP
05360L403
Shares Outstanding
3,294,967
Website
https://www.avenuetx.com
Investor Relations
https://avenuetx.com/investors/
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $0 | 10-K, filed 2024-03-18 |
| 2022-12-31 | $1,104,000 | 10-K, filed 2024-03-18 |